Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients 21. Mai 2021 Metz, M., Semsek, D., Rogmans, G., Hutzschenreuter, U., Fietz, T., Harde, J., Zacharias, S., Hielscher, C., Lorenz, A., Zahn, M.-O., Guth, D., Liebers, S., Berghorn, M., Grebhardt, S., Matillon, C. D., Egerer, G., Potthoff, K., 2021. Abstract Download An epidemiological, prospective cohort study for patients with HR+/HER2- advanced breast cancer treated 1st-line with an endocrine-based palbociclib combination therapy in real world in Germany and Austria Lux, M. P., Resch, T., Fuxius, S., Gabrysiak, T., Amann, E., Buncke, J., Frank, M., Runkel, E. D., Thill, M., 2021. Download… Weiterlesen Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial. Staehler, M., Stöckle, M., Christoph, D. C., Stenzl, A., Potthoff, K., Grimm, M.-O., Klein, D., Harde, J., Brüning, F., Goebell, P. J., Augustin, M., Roos,… Weiterlesen